Etidaligide

N/A

Report date: 2022/05/30 17:28:59
NME

Base Information

Drug NameEtidaligide
Drug Alias NameDNA baitDNA repair therapeutic - OnxeoDbait32HDSB baitDbait +[8] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionDNA-dependent protein kinase inhibitors
TargetsDNA-dependent protein kinase
Therapy Area/IndicationsIrritable Bowel SyndromeProstatic Neoplasms, Castration-ResistantBreast Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesVietnam +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesValerio Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesInstitut Curie ParisCentre Of Clinical Pharmacology, Hanoi Medical UniversityValerio Therapeutics SA
Inactive CompaniesInstitut Curie
Active IndicationsIrritable Bowel SyndromeProstatic Neoplasms, Castration-ResistantBreast Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A